JP2015518837A5 - - Google Patents

Download PDF

Info

Publication number
JP2015518837A5
JP2015518837A5 JP2015512890A JP2015512890A JP2015518837A5 JP 2015518837 A5 JP2015518837 A5 JP 2015518837A5 JP 2015512890 A JP2015512890 A JP 2015512890A JP 2015512890 A JP2015512890 A JP 2015512890A JP 2015518837 A5 JP2015518837 A5 JP 2015518837A5
Authority
JP
Japan
Prior art keywords
compound
salt
formula
process according
forming
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015512890A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015518837A (ja
JP6214636B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2013/041624 external-priority patent/WO2013173736A1/en
Publication of JP2015518837A publication Critical patent/JP2015518837A/ja
Publication of JP2015518837A5 publication Critical patent/JP2015518837A5/ja
Application granted granted Critical
Publication of JP6214636B2 publication Critical patent/JP6214636B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2015512890A 2012-05-17 2013-05-17 ヒドロキシル化シクロペンチルピリミジン化合物を作製するためのプロセス Active JP6214636B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201261648421P 2012-05-17 2012-05-17
US61/648,421 2012-05-17
US201361785281P 2013-03-14 2013-03-14
US61/785,281 2013-03-14
PCT/US2013/041624 WO2013173736A1 (en) 2012-05-17 2013-05-17 Process for making hydroxylated cyclopentylpyrimidine compounds

Publications (3)

Publication Number Publication Date
JP2015518837A JP2015518837A (ja) 2015-07-06
JP2015518837A5 true JP2015518837A5 (enExample) 2016-07-07
JP6214636B2 JP6214636B2 (ja) 2017-10-18

Family

ID=48534507

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015512890A Active JP6214636B2 (ja) 2012-05-17 2013-05-17 ヒドロキシル化シクロペンチルピリミジン化合物を作製するためのプロセス

Country Status (18)

Country Link
US (1) US9309204B2 (enExample)
EP (1) EP2861583B1 (enExample)
JP (1) JP6214636B2 (enExample)
KR (1) KR20150020211A (enExample)
CN (1) CN104487430B (enExample)
AU (1) AU2013262568B2 (enExample)
BR (1) BR112014028570A2 (enExample)
CA (1) CA2873653A1 (enExample)
DK (1) DK2861583T3 (enExample)
ES (1) ES2588878T3 (enExample)
IL (1) IL235714A0 (enExample)
MA (1) MA37649B1 (enExample)
MX (1) MX2014013865A (enExample)
PL (1) PL2861583T3 (enExample)
RU (1) RU2014151017A (enExample)
SG (1) SG11201407613RA (enExample)
SI (1) SI2861583T1 (enExample)
WO (1) WO2013173736A1 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2861582T3 (en) 2012-05-17 2016-08-22 Array Biopharma Inc A process for preparing hydroxylated compounds cyclopentylpyrimidin
KR102074535B1 (ko) 2012-05-17 2020-02-06 제넨테크, 인크. 아미노산 화합물의 제조 방법
SG11201407618VA (en) 2012-05-17 2015-01-29 Genentech Inc Amorphous form of an akt inhibiting pyrimidinyl - cyclopentane compound, compositions and methods thereof
EP2850200A1 (en) 2012-05-17 2015-03-25 Genentech, Inc. Process of making hydroxylated cyclopentapyrimidine compounds and salts thereof
CN105899492B (zh) 2013-11-15 2021-08-24 豪夫迈·罗氏有限公司 用于制备嘧啶基环戊烷化合物的方法
AU2014356984B2 (en) * 2013-11-27 2018-01-04 Sunshine Lake Pharma Co., Ltd. Processes for preparing dihydropyrimidine derivatives and intermediates thereof
CA2962901A1 (en) * 2014-09-26 2016-03-31 F.Hoffmann-La Roche Ag Processes for preparing (cyclopentyl[d]pyrimidin-4-yl)piperazine compounds
CN115916758A (zh) 2020-06-16 2023-04-04 豪夫迈·罗氏有限公司 用于制备羟基化环戊基嘧啶化合物的方法
KR102689151B1 (ko) * 2021-09-06 2024-07-29 연세대학교 산학협력단 Akt 신호경로 억제제를 유효성분으로 포함하는 아토피피부염의 예방 또는 치료용 조성물

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH09506369A (ja) 1993-12-12 1997-06-24 アグロジーン・リミテッド 菌類感染から植物を保護するための新規方法
JP2001524079A (ja) 1997-04-07 2001-11-27 メルク エンド カンパニー インコーポレーテッド ガンの治療方法
US6201023B1 (en) 1997-06-10 2001-03-13 Agrogene Ltd. Methods and compositions to protect crops against plant parasitic nematodes
EP0982300A3 (en) 1998-07-29 2000-03-08 Societe Civile Bioprojet Non-imidazole alkylamines as histamine H3 - receptor ligands and their therapeutic applications
AU3386600A (en) 1999-03-03 2000-09-21 Merck & Co., Inc. Inhibitors of prenyl-protein transferase
ES2239596T3 (es) * 1999-06-03 2005-10-01 Teikoku Hormone Mfg. Co., Ltd. Compuestos de pirazol sustituidos.
WO2001022963A1 (en) 1999-09-27 2001-04-05 Merck & Co., Inc. Method of preventing osteoporosis
JP4550811B2 (ja) 2003-06-09 2010-09-22 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング パピローマウイルスのインヒビター
AU2004293026B2 (en) 2003-11-21 2012-01-19 Array Biopharma Inc. AKT protein kinase inhibitors
US8927546B2 (en) 2006-02-28 2015-01-06 Dart Neuroscience (Cayman) Ltd. Therapeutic piperazines
US8063050B2 (en) * 2006-07-06 2011-11-22 Array Biopharma Inc. Hydroxylated and methoxylated pyrimidyl cyclopentanes as AKT protein kinase inhibitors
UA95641C2 (xx) * 2006-07-06 2011-08-25 Эррей Биофарма Инк. Гідроксильовані піримідильні циклопентани як інгібітори акт протеїнкінази$гидроксилированные пиримидильные циклопентаны как ингибиторы акт протеинкиназы
JP5157576B2 (ja) 2007-05-14 2013-03-06 住友化学株式会社 光学活性2−アルキル−1,1,3−トリアルコキシカルボニルプロパンの製造方法
KR20150091196A (ko) * 2007-07-05 2015-08-07 어레이 바이오파마 인크. Akt 단백질 키나제 억제제로서의 피리미딜 시클로펜탄
EP2209775A1 (en) 2007-10-09 2010-07-28 UCB Pharma, S.A. Heterobicyclic compounds as histamine h4-receptor antagonists
CA2711699A1 (en) * 2008-01-09 2009-07-16 Array Biopharma Inc. Hydroxylated pyrimidyl cyclopentanes as akt protein kinase inhibitors
JP5551707B2 (ja) * 2008-10-15 2014-07-16 アムジエン・インコーポレーテツド スピロ環gpr40調節因子
JP5734956B2 (ja) 2009-04-15 2015-06-17 アッヴィ・インコーポレイテッド 抗ウィルス化合物
KR101398268B1 (ko) * 2009-10-23 2014-05-23 일라이 릴리 앤드 캄파니 Akt 억제제
US9050334B2 (en) 2010-07-16 2015-06-09 Innov88 Llc MIF inhibitors and their uses
WO2012177925A1 (en) 2011-06-21 2012-12-27 The Board Institute, Inc. Akt inhibitors for treating cancer expressing a magi3 - akt3 fusion gene
KR102074535B1 (ko) 2012-05-17 2020-02-06 제넨테크, 인크. 아미노산 화합물의 제조 방법
EP2850200A1 (en) 2012-05-17 2015-03-25 Genentech, Inc. Process of making hydroxylated cyclopentapyrimidine compounds and salts thereof
DK2861582T3 (en) 2012-05-17 2016-08-22 Array Biopharma Inc A process for preparing hydroxylated compounds cyclopentylpyrimidin
US20140121193A1 (en) 2012-11-01 2014-05-01 Robert S. Katz Methods for treating fibromyalgia
CA2901577A1 (en) 2013-02-18 2014-08-21 The Scripps Research Institute Modulators of vasopressin receptors with therapeutic potential
US10131637B2 (en) 2013-03-15 2018-11-20 Shifa Biomedical Corporation Anti-PCSK9 compounds and methods for the treatment and/or prevention of cardiovascular diseases

Similar Documents

Publication Publication Date Title
JP2015518837A5 (enExample)
RU2014151017A (ru) Способ получения гидроксилированных циклопентилпиримидинов
JP2012506425A5 (enExample)
JP2011121989A5 (enExample)
JP2012140458A5 (enExample)
JP2014511367A5 (enExample)
JP2013147496A5 (ja) 有機金属錯体
MX343621B (es) Fluoracion catalitica en fase gas.
JP2015512868A5 (ja) ビニルエステル及び酢酸又はプロピオン酸反応生成物の共製造の第一段階としてのトランスビニル化
JP2016515039A5 (enExample)
IL229800A (en) Method of production of bicyclic compound by iminium salt
BR112018004447A2 (pt) derivado de biarila e medicamento contendo o mesmo
RU2019119584A (ru) Способ получения триазолопиридинового соединения
JP2013531058A5 (enExample)
JP2017509581A5 (enExample)
JP2014520075A5 (enExample)
JP2018009003A5 (enExample)
CU24173B1 (es) Compuestos derivados de tieno [2,3-d] pirimidina para el tratamiento de la arritmia
JP2013241421A5 (enExample)
HRP20191632T1 (hr) Kemijski postupak dobivanja spiroindolona i njihovih međuprodukata
JP2014508714A5 (enExample)
AU2012264476A8 (en) Process for the preparation of paliperidone
JP2016040296A5 (enExample)
RU2015118152A (ru) Новое сложноэфирное соединение алициклической дикарбоновой кислоты и способ его изготовления
MX358245B (es) Proceso para la preparación de voriconazol y análogos del mismo.